Last reviewed · How we verify
NCT04105075
COPD in Obese Patients
trial in Copd in 176 participants. Completed in 20 September 2019.
10 September 2019
Quick facts
| Lead sponsor | Voronezh N.N. Burdenko State Medical Academy |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 176 |
| Start date | 9 September 2018 |
| Primary completion | 10 September 2019 |
| Estimated completion | 20 September 2019 |
| Sites | 1 location across Russia |
Conditions studied
- Copd — all drugs for Copd →
- Obese — all drugs for Obese →
- Obesity, Abdominal — all drugs for Obesity, Abdominal →
Sponsor
Voronezh N.N. Burdenko State Medical Academy
Who can join
Adults 30 to 70, any sex, with Copd or Obese. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study included 176 patients with COPD. The first group included 88 normal weight patients with COPD: 71 men and 17 women, mean age 62.40 ± 8.83 years. The second group included 88 patients with COPD and obesity: 64 men and 24 women, mean age 62.94 ± 5.96 years. We assessed the frequency of COPD exacerbations in last 12 months, the severity of symptoms such as dyspnea, sputum production, fatigue. Spirometry, six-minute walk test and analysis of body tissue type composition were performed. BODE index was calculated. Levels of leptin, adiponectin, interleukins-4,6,8,10, interferon-γ, c-reactive protein (CRP), tumor necrosis factor receptor 1 (TNF-R1), tumor necrosis factor receptor 2 (TNF-R2), tumor necrosis factor alpha (TNF-α) were measured in blood serum.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04105075
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Copd
Currently open trials in the same condition.
- NCT06461403 — Inhaler Trainer Efficacy Study · NA · recruiting
- NCT07285642 — Brain and Peripheral Muscle Oxygenation in Patients With Chronic Obstructive Pulmonary Disease · NA · recruiting
- NCT07027852 — My Lung Health Coach-A Virtual COPD Self-management Support Program Integrated Into the Electronic Patient Record · NA · recruiting
- NCT06286072 — The Effect of Education and Reminder Messages on the Fatigue Level of Individuals With COPD · NA · recruiting
- NCT06304207 — Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease · NA · recruiting
Other Voronezh N.N. Burdenko State Medical Academy trials
Trials by the same sponsor.
- NCT06392334 — Mast Cells and Its Proteases in COPD · NA · recruiting
- NCT04239118 — New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04105075 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Voronezh N.N. Burdenko State Medical Academy
- Last refreshed: 3 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04105075.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing